Dr Pavel Osmančik (Senior Physician, Department of Arrhythmology, University Hospital Královské Vinohrady, Prague, Czech Republic) spoke with us at Heart Rhythm 2019 about the Surgical Treatment of Atrial Fibrillation – Prospective Randomized Study (PRAGUE-12). This examined the five-year outcomes in cardiac surgery for patients with atrial fibrillation undergoing concomitant surgical ablation versus no ablation.
Filmed at Heart Rhythm 2019, San Francisco, CA, USA.
Speaker’s Disclosures: Pavel Osmančik has nothing to disclose in relation to this video interview.
1. The Surgical Treatment of Atrial Fibrillation – Prospective Randomized Study (PRAGUE-12) examined the impact of the addition of concomitant surgical ablation in patients with atrial fibrillation who were referred for cardiac surgery. What were the initial findings? (0:08)
2. What new evidence has been provided by the recent long-term follow up evaluations? (2:06)
3. What are the current unmet needs in cardiac surgery patients with atrial fibrillation? (2:39)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Atrial Fibrillation
Faizel Osman, A-A Heart Rhythm Updates 2021: 2020 ESC AF Guidelines
We spoke to Professor Faizel Osman (Consultant Cardiologist and Electrophysiologist, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK) who gave us an update about the recent new ESC Guidelines for Atrial Fibrillation and the upcoming Arrhythmia Alliance Heart Rhythm Updates 2021. Questions What are the most important new recommendations in the 2020 ESC atrial […]
Suneet Mittal, AF Symposium 2021: Atrial Fibrillation in the Post-COVID-19 Environment
We spoke to Dr Suneet Mittal (Director of Electrophysiology, The Valley Hospital, Ridgewood, NJ, USA) about the workflow innovations for atrial fibrillation ablation in the post-COVID-19 environment. Questions What have been the main challenges to atrial fibrillation (AF) ablation workflow during the COVID-19 pandemic? (0.14) What workflow innovations have been created and incorporated over the […]
Hugh Calkins, AF Symposium 2021: the STOP Persistent AF Clinical Trial
We spoke to Professor Hugh Calkins (Johns Hopkins Hospital, Baltimore, MD, USA) about the STOP Persistent AF Clinical Trial (NCT03012841). Questions: Could you tell us a little about the aims and design of the STOP Persistent AF clinical trial? (0.13) What were the findings of the study? (0.43) What are their implications for clinical practice? […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!